Keywords: عوارض جانبی جدی; 25; 41.1; AE; adverse event; AT; antithrombin; CPB; cardiopulmonary bypass; HR; heparin reistance; ICU; intensive care unit; SAE; serious adverse event;
مقالات ISI عوارض جانبی جدی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عوارض جانبی جدی; AE; adverse event; CI; confidence interval; CRM197; cross-reactive material 197; GMR; geometric mean ratio; GMT; geometric mean titer; IPD; invasive pneumococcal disease; LLOQ; lower limit of quantitation; LOD; limit of detection; OPA; opsonophagocytic ac
Keywords: عوارض جانبی جدی; %FVC; percent predicted forced vital capacity; 6MWT; six-minute walk test; Ab +; antibody positive; Ab â; antibody negative; AEs; adverse events; CSA; conformation-specific antibody assay; ELISA; enzyme-linked immunosorbent assay; FVC; forced vital ca
Keywords: عوارض جانبی جدی; ACIP; United States Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; CRM197; cross-reactive material 197; GMR; geometric mean ratio; GMT; geometric mean titer; OPA; opsonophagocytic activity; PCV; pneumococcal poly
Keywords: عوارض جانبی جدی; AE; Adverse event; GER; Gastroesophageal reflux; GERD; Gastroesophageal reflux disease; LSM; Least square mean; ITT; Intent-to-treat; PPI; Proton pump inhibitor; SAE; Serious adverse event;
Keywords: عوارض جانبی جدی; albaconazole; dermatophyte; nail fungus; onychomycosis; phase II study; triazole; AE; adverse event; ECG; electrocardiogram; ITT; intent to treat; KOH; potassium hydroxide; PK; pharmacokinetic; PP; per protocol; SAE; serious adverse event; SD; standard de
Keywords: عوارض جانبی جدی; AEFI; Adverse Event Following Immunization; CIOMS; Council for International Organizations of Medical Sciences; CRF; Case Report Form; CSP; Central Safety Physician; DSMB; Data and Safety Monitoring Board; FDA; United States Food and Drug Administration;
Long-term follow-up of HIV-1-infected adults who received the F4/AS01B HIV-1 vaccine candidate in two randomised controlled trials
Keywords: عوارض جانبی جدی; HIV type 1 vaccine; Recombinant fusion protein; Persistence; Efficacy; Immunogenicity; Safety; AE; adverse event; ART; antiretroviral therapy; ATP; according-to-protocol; CI; confidence interval; GMC; geometric mean concentration; HIV-1; human immunodefic
Efficacy of Growth Hormone Treatment in Children with Type 1 Diabetes Mellitus and Growth Hormone Deficiency-An Analysis of KIGS Data
Keywords: عوارض جانبی جدی; growth hormone deficiency; type 1 diabetes; growth hormone treatment; AE; Adverse event; DPV; Diabetes Prospektive Verlaufsdokumentation; GH; Growth hormone; GHD; Growth hormone deficiency; IGFBP-3; Insulin-like growth factor-binding protein 3; IGF-I; Ins
Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer
Keywords: عوارض جانبی جدی; NSCLC; non-small cell lung cancer; IrAE; immune-related adverse event; PFS; progression-free survival; OS; overall survival; CMI; Charlson's comorbidity index; ECOG; Eastern Cooperative Oncology Group; ADR; adverse drug reaction; SAE; serious adverse even
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vacci
Keywords: عوارض جانبی جدی; AE; adverse event; ap; acellular pertussis; ATP; according to protocol; CI; confidence interval; d; diphtheria (low dose); D; diphtheria, (high dose); dTap-IPV; reduced antigen diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine; ELISA;
Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study
Keywords: عوارض جانبی جدی; Asplenia; Neisseria meningitidis; Meningococcal disease; Meningococcal vaccine; Immunogenicity; Safety; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; GMC; geometric mean concent
Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated with Cataract Surgery
Keywords: عوارض جانبی جدی; ACC; anterior chamber cell; ACF; anterior chamber flare; AE; adverse event; IOP; intraocular pressure; NSAID; nonsteroidal anti-inflammatory drug; POD; postoperative day; SAE; serious adverse event;
Study Design and Rationale: A Multicenter, Prospective Trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoracic Navigational Approaches for the Biopsy of Peripheral Pulmonary Nodules (ALL IN ONE Trial)
Keywords: عوارض جانبی جدی; Electromagnetic navigation; Bronchoscopy; Pulmonary nodule; Transthoracic biopsy; ACCP; American College of Chest Physicians; AE; adverse event; ALL IN ONE; A Multicenter, Prospective Trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoraci
Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15â¯months: A phase III, randomized, non-inferiority trial
Keywords: عوارض جانبی جدی; MMR vaccine; Measles; Mumps; Rubella; Immunogenicity; Safety; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; GMC; geometric mean concentration; GMT; geometric mean titer; HAV; hepatitis A
Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity
Keywords: عوارض جانبی جدی; botulism; botulinum neurotoxin; Human Botulism Immune Globulin; infant botulism; pentavalent botulinum toxoid; recombinant botulinum vaccine; AEs; adverse events; AUC; area under the plasma concentration-time curve; BIG-IV; Human Botulism Immune Globulin
Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5â¯years of treatment
Keywords: عوارض جانبی جدی; Morquio A; Mucopolysaccharidosis IVA; Long-term extension; Elosulfase alfa; 3MSCT; 3-min stair climb test; 6MWT; 6-min walk test; AE; adverse event; AUC0ât; area under the curve from time 0 to last measurable concentration; AUCinf; area under the curve
Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study
Keywords: عوارض جانبی جدی; AE; adverse event; BCVA; best-corrected visual acuity; CFT; central foveal thickness; CRC; central reading center; CRVO; central retinal vein occlusion; CSFT; central subfield thickness; ETDRS; Early Treatment Diabetic Retinopathy Study; FAS; full analysi
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study
Keywords: عوارض جانبی جدی; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; GMC; geometric mean concentration; GMT; geometric mean titre; hSBA; human complement serum bactericidal antibody assay; MenACWY-TT; quadrival
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14â¯years: Results to month 36 from a randomized trial
Keywords: عوارض جانبی جدی; 2D; 2-dose; 3D; 3-dose; AAHS; aluminum hydroxyphosphate sulphate; AE; adverse event; ANOVA; analysis of variance; AS04; Adjuvant System containing 50 µg 3-O-desacyl-4â²-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 µg Al3+); ATP; accordin
Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults
Keywords: عوارض جانبی جدی; Reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine; Persistence; Booster immunization; Adults; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; DTPa; combined diphtheria-tetanus toxoids-acellular pertussis va
Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized stu
Keywords: عوارض جانبی جدی; Quadrivalent meningococcal conjugate vaccine; Combined diphtheria-tetanus-acellular pertussis vaccine; Co-administration; Immunogenicity; Safety; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; D; diphtheria; ELISA; enzyme-linked i
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
Keywords: عوارض جانبی جدی; ACMG; American College of Medical Genetics and Genomics; ADHD RS-IV IA; Attention Deficit Hyperactivity Disorder Rating Scale IV inattention subscale; AE; adverse event; CTCAE; Common Terminology Criteria for Adverse Events; DMC; Data Monitoring Committee
Adapted Surgical Procedure for Argus II Retinal Implantation: Feasibility, Safety, Efficiency, and Postoperative Anatomic Findings
Keywords: عوارض جانبی جدی; AE; adverse event; IOP; intraocular pressure; IQR; interquartile range; OCT; optical coherence tomography; RP; retinitis pigmentosa; SAE; serious adverse event; SD-OCT; spectral-domain optical coherence tomography;
Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis
Keywords: عوارض جانبی جدی; Direct-Acting Antiviral Agent; Outcome; Drug Resistance; AE; adverse event; HCV; hepatitis C virus; HIV; human immunodeficiency virus; NS5A; nonstructural protein 5A; NS5B; nonstructural protein 5B; RAS; resistance-associated substitution; SAE; serious ad
Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device
Keywords: عوارض جانبی جدی; echocardiography; mitral valve; regurgitation; valvuloplasty; surgery; CI; confidence interval; ePTFE; expanded polytetrafluoroethylene; H-MVRS; Harpoon mitral valve repair system; IQR; interquartile range; LA; left atrial; LV; left ventricular; MAC; mitr
Global Prospective Safety Analysis of Rivaroxaban
Keywords: عوارض جانبی جدی; atrial fibrillation; real-world; rivaroxaban; safety; stroke prevention; XANTUS; AE; adverse event; AF; atrial fibrillation; CNS; central nervous system; CrCl; creatinine clearance; DOAC; direct oral anticoagulant; ICH; intracranial hemorrhage; ISTH; Inte
Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease
Keywords: عوارض جانبی جدی; TNF inhibitor; immune-mediated inflammatory diseases; children; AE; Adverse event; CD; Crohn's disease; CHF; Congestive heart failure; ERA; Enthesitis-related arthritis; JIA; Juvenile idiopathic arthritis; NCT; National Clinical Trial; pJIA; Polyarticular
The Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula Creation for Hemodialysis Access
Keywords: عوارض جانبی جدی; AVF; arteriovenous fistula; ITT; intent-to-treat; SAE; serious adverse event; TRAD; thermal resistance anastomosis device;
One-Year Analysis of the Prospective Multicenter SENTRY Clinical Trial: Safety and Effectiveness of the Novate Sentry Bioconvertible Inferior Vena Cava Filter
Keywords: عوارض جانبی جدی; CEC; clinical events committee; CI; confidence interval; DVT; deep vein thrombosis; FDA; US Food and Drug Administration; IDE; investigational device exemption; IVC; inferior vena cava; PE; pulmonary embolism; SAE; serious adverse event; VTE; venous throm
Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures
Keywords: عوارض جانبی جدی; AE; adverse event; AED; antiepileptic drug; CBZ; carbamazepine; +CBZ; patients who were taking concomitant CBZ; -CBZ; patients who were not taking concomitant CBZ; ESL; eslicarbazepine acetate; FS; focal seizures; LEV; levetiracetam; LCM; lacosamide; LT
Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders
Keywords: عوارض جانبی جدی; Gastroparesis; Chronic Nausea and Vomiting; Aprepitant Treatment; RCT; AE; adverse event; ANCOVA; analysis of covariance; APRON; Aprepitant for the Relief of Nausea in patients with gastroparesis or chronic nausea and vomiting of presumed gastric origin;
MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study
Keywords: عوارض جانبی جدی; AE; adverse event; CI; confidence interval; HiSCR; hidradenitis suppurativa clinical response score; HS; hidradenitis suppurativa; OR; odds ratio; SAE; serious adverse event;
Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 study
Keywords: عوارض جانبی جدی; AE; adverse event; ANCOVA; analysis of covariance; ARR; annualized relapse rate; CI; confidence interval; EDSS; Expanded Disability Status Scale; Gd+; gadolinium-enhancing; iDMT; injectable disease-modifying therapy; MRI; magnetic resonance imaging; MS; m
Safety and pharmacokinetics of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (BGF MDI) in healthy adult subjects of Japanese descent
Keywords: عوارض جانبی جدی; Chronic obstructive pulmonary disease; Co-suspension delivery technology; ICS/LAMA/LABA; Western; Japanese; Triple fixed-dose combination; AE; adverse event; AUC0-12; area under the plasma concentration-time curve from 0 to 12â¯h; AUC0-â; area un
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial
Keywords: عوارض جانبی جدی; Antibody persistence; Meningococcal B vaccine; Infants; Children; Booster response; 2Â +Â 1 schedule; Safety; Open-label randomised clinical trial; AE; adverse event; CI; confidence interval; FAS; full analysis set; fHbp; factor H-binding protein; GMT; ge
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)
Keywords: عوارض جانبی جدی; AE; adverse event; ARR; annualized relapse rate; DMF; dimethyl fumarate; DMT; disease-modifying therapy; HR; hazard ratio; IPTW; inverse probability of treatment weight; JCV; John Cunningham virus; MS; multiple sclerosis; PML; progressive multifocal leuko
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen
Keywords: عوارض جانبی جدی; PIKA adjuvant; Rabies vaccine; Immunogenicity; Safety; TLR3; Phase II; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; CIRB; Centralised Institutional Review Board; CSIRO; Commonwealth Scientific and Industr
Serious Adverse Events with Bevacizumab or Ranibizumab for Age-Related Macular Degeneration: Meta-analysis of Individual Patient Data
Keywords: عوارض جانبی جدی; AMD; age-related macular degeneration; APTC; Antiplatelet Trialists' Collaboration; BRAMD; Bevacizumab and Ranibizumab in Age-Related Macular Degeneration; CATT; Comparison of Age-Related Macular Degeneration Treatment Trials; CI; confidence interval; GEF
Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month ex
Keywords: عوارض جانبی جدی; Glycaemic control; Hypoglycaemia; Insulin glargine; Type 2 diabetes; AE; adverse event; ANCOVA; analysis of covariance; BL; baseline; BMI; body mass index; CI; confidence interval; FPG; fasting plasma glucose; Gla-100; glargine 100; Gla-300; glargine 300;
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2-17-year-old children with asplenia or splenic dysfunction: A phase 3 study
Keywords: عوارض جانبی جدی; Pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV); Immunogenicity; Safety; Asplenia; Splenic dysfunction; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay
Patient safety during sedation by anesthesia professionals during routine upper endoscopy and colonoscopy: an analysis of 1.38 million procedures
Keywords: عوارض جانبی جدی; ADS; anesthesia-directed sedation; ASA; American Society of Anesthesiologists; CORI; Clinical Outcomes Research Initiative; EDS; endoscopist-directed sedation; NED; National Endoscopic Database; OR; odds ratio; SAE; serious adverse event;
Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial
Keywords: عوارض جانبی جدی; AE; adverse event; AESI; adverse event of specific interest; AS; adjuvant system; CBER; Center for Biologics Evaluation and Research; CHMP; Committee for Medicinal Products for Human Use; CI; confidence interval; EMA; European Medicines Agency; GMT; geome
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65Â years of age and older: A phase II, observer-blind, randomized, controlled trial
Keywords: عوارض جانبی جدی; H7N1; H7N9; Pandemic flu; H7 influenza vaccine; AS03 adjuvant; Elderly population; AE; adverse event; CI; confidence interval; GMT; geometric mean titers; HA; hemagglutinin; HI; hemagglutination inhibition; MGI; mean geometric increase; MN; microneutraliz
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial
Keywords: عوارض جانبی جدی; AE; adverse event; CBER; Center for Biologics Evaluation and Research; CHMP; Committee for Medical Products for Human Use; CI; confidence interval; GMT; geometric mean titers; HA; hemagglutinin; HI; hemagglutination-inhibition; MGI; mean geometric increas
Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study
Keywords: عوارض جانبی جدی; Immunogenicity; Inactivated; Influenza vaccine; Noninferiority; Quadrivalent; Safety; AE; adverse event; CI; confidence interval; DSMB; Data and Safety Monitoring Board; FAS; full analysis set; GMFI; geometric mean fold increase; GMT; geometric mean titer
Comparing diagnostic yield of a novel pan-enteric video capsule endoscope with ileocolonoscopy in patients with active Crohn's disease: a feasibility study
Keywords: عوارض جانبی جدی; AE; adverse event; CD; Crohn's disease; CE; capsule endoscopy; CI; confidence interval; ESR; erythrocyte sedimentation rate; IC; ileocolonoscopy; MRI; magnetic resonance imaging; PEG; polyethylene glycol; SAE; serious adverse event; SBC; small-bowel col
Persistence With Dabigatran Therapy at 2Â Years in Patients With Atrial Fibrillation
Keywords: عوارض جانبی جدی; discontinuation; non-VKA oral anticoagulant; oral anticoagulation; stroke prevention; vitamin K antagonist; AE; adverse event; AF; atrial fibrillation; CI; confidence interval; HR; hazard ratio; NOAC; non-vitamin K oral anticoagulant; OAC; oral anticoag
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants
Keywords: عوارض جانبی جدی; ATP; according-to-protocol; ACIP; Advisory Committee on Immunization Practice; AE; adverse events; AESI; adverse event of specific interest; CI; confidence interval; DTaP; diphtheria-tetanus-acellular pertussis; ELISA; enzyme-linked immunosorbent assay; G
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma
Keywords: عوارض جانبی جدی; Adverse event; arterial thromboembolic event; clinical trials; moderate to severe asthma; omalizumab; safety; serious adverse event; ATE; Arterial thromboembolic event; CBV; Cerebrovascular; CV; Cardiovascular; EXCELS; Epidemiologic Study of Xolair (Omali